128 related articles for article (PubMed ID: 17331940)
1. [Saccharomyces boulardii fungal sepsis: beware of the yeast].
Piechno S; Seguin P; Gangneux JP
Can J Anaesth; 2007 Mar; 54(3):245-6. PubMed ID: 17331940
[No Abstract] [Full Text] [Related]
2. Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.
Herbrecht R; Nivoix Y
Clin Infect Dis; 2005 Jun; 40(11):1635-7. PubMed ID: 15889361
[No Abstract] [Full Text] [Related]
3. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum.
Santino I; Alari A; Bono S; Teti E; Marangi M; Bernardini A; Magrini L; Di Somma S; Teggi A
Int J Immunopathol Pharmacol; 2014; 27(1):143-6. PubMed ID: 24674691
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
Martin IW; Tonner R; Trivedi J; Miller H; Lee R; Liang X; Rotello L; Isenbergh E; Anderson J; Perl T; Zhang SX
Diagn Microbiol Infect Dis; 2017 Mar; 87(3):286-288. PubMed ID: 28024866
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii fungemia caused by treatment with a probioticum.
Thygesen JB; Glerup H; Tarp B
BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605806
[TBL] [Abstract][Full Text] [Related]
6. Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient.
Kara I; Yıldırım F; Özgen Ö; Erganiş S; Aydoğdu M; Dizbay M; Gürsel G; Kalkanci A
J Mycol Med; 2018 Mar; 28(1):218-221. PubMed ID: 29132794
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
[TBL] [Abstract][Full Text] [Related]
8. Possible role of catheters in Saccharomyces boulardii fungemia.
Hennequin C; Kauffmann-Lacroix C; Jobert A; Viard JP; Ricour C; Jacquemin JL; Berche P
Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):16-20. PubMed ID: 10706174
[TBL] [Abstract][Full Text] [Related]
9. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin.
Lolis N; Veldekis D; Moraitou H; Kanavaki S; Velegraki A; Triandafyllidis C; Tasioudis C; Pefanis A; Pneumatikos I
Crit Care; 2008; 12(2):414. PubMed ID: 18423057
[TBL] [Abstract][Full Text] [Related]
10. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis.
Cherifi S; Robberecht J; Miendje Y
Acta Clin Belg; 2004; 59(4):223-4. PubMed ID: 15597730
[TBL] [Abstract][Full Text] [Related]
11. [Saccharomyces cerevisiae fungemia in a premature neonate treated receiving probiotics].
Chioukh FZ; Ben Hmida H; Ben Ameur K; Toumi A; Monastiri K
Med Mal Infect; 2013 Aug; 43(8):359-60. PubMed ID: 23876201
[No Abstract] [Full Text] [Related]
12. [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities].
Lestin F; Pertschy A; Rimek D
Dtsch Med Wochenschr; 2003 Nov; 128(48):2531-3. PubMed ID: 14648435
[TBL] [Abstract][Full Text] [Related]
13. Seven cases of Saccharomyces fungaemia related to use of probiotics.
Roy U; Jessani LG; Rudramurthy SM; Gopalakrishnan R; Dutta S; Chakravarty C; Jillwin J; Chakrabarti A
Mycoses; 2017 Jun; 60(6):375-380. PubMed ID: 28133894
[TBL] [Abstract][Full Text] [Related]
14. [Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment].
Eren Z; Gurol Y; Sonmezoglu M; Eren HS; Celik G; Kantarci G
Mikrobiyol Bul; 2014 Apr; 48(2):351-5. PubMed ID: 24819274
[TBL] [Abstract][Full Text] [Related]
15. Invasive infections due to Saccharomyces boulardii (Ultra-levure).
Prescrire Int; 2007 Jun; 16(89):110. PubMed ID: 17582930
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces cerevisiae fungemia: an emerging infectious disease.
Muñoz P; Bouza E; Cuenca-Estrella M; Eiros JM; Pérez MJ; Sánchez-Somolinos M; Rincón C; Hortal J; Peláez T
Clin Infect Dis; 2005 Jun; 40(11):1625-34. PubMed ID: 15889360
[TBL] [Abstract][Full Text] [Related]
17. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host.
Rijnders BJ; Van Wijngaerden E; Verwaest C; Peetermans WE
Intensive Care Med; 2000 Jun; 26(6):825. PubMed ID: 10945412
[No Abstract] [Full Text] [Related]
18. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii.
Niault M; Thomas F; Prost J; Ansari FH; Kalfon P
Clin Infect Dis; 1999 Apr; 28(4):930. PubMed ID: 10825077
[No Abstract] [Full Text] [Related]
19. Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.
Burkhardt O; Köhnlein T; Pletz M; Welte T
Scand J Infect Dis; 2005; 37(1):69-72. PubMed ID: 15764194
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.
Riquelme AJ; Calvo MA; Guzmán AM; Depix MS; García P; Pérez C; Arrese M; Labarca JA
J Clin Gastroenterol; 2003 Jan; 36(1):41-3. PubMed ID: 12488707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
